How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
2% Chlorhexidine Gluconate (CHG) Cloths Market
- By Product Type: Pre-moistened Cloths, Sterile Wipes, Non-sterile Wipes, Surgical Scrub Cloths, Patient Preoperative Cloths
- By End-Use Application: Preoperative Skin Preparation, Hand Hygiene, Environmental Surface Disinfection, Patient Decolonization, Medical Device Disinfection
- By Distribution Channel: Hospital Pharmacies, Direct Hospital Procurement, Online Medical Suppliers, Retail Pharmacies, Wholesale Distributors
- By Formulation Type: Alcohol-based CHG Cloths, Non-alcohol CHG Cloths, Combination Antiseptic Cloths (CHG with Isopropyl Alcohol)
- By User Type: Healthcare Professionals, Patients, Caregivers, Veterinary Use
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Pre-moistened Cloths leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the 2% Chlorhexidine Gluconate (CHG) Cloths Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
End-Use Application 5
Distribution Channel 5
Formulation Type 3
User Type 4
Companies profiled
3M Company
Sage Products LLC (a division of Stryker)
Mölnlycke Health Care
Medline Industries Inc.
Avanos Medical Inc.
Dynarex Corporation
Cardinal Health Inc.
B. Braun Melsungen AG
ConvaTec Group PLC
Smith & Nephew plc
Paul Hartmann AG
Covidien (Medtronic)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →3M Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Sage Products LLC (a division of Stryker)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Mölnlycke Health Care
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Medline Industries Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Avanos Medical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Dynarex Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Cardinal Health Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →ConvaTec Group PLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Smith & Nephew plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Paul Hartmann AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Covidien (Medtronic)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Halyard Health (now part of Owens & Minor)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Molnlycke Health Care AB
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →MediPro Medikal
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,581M by 2033 · 10.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Pre-moistened Cloths43.7
- Sterile Wipes16.9
- Non-sterile Wipes16.4
- Surgical Scrub Cloths11.2
- Patient Preoperative Cloths11.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,440M → $3,258M · 10.7%
Europe$1,004M → $2,398M · 11.5%
Asia Pacific$916.4M → $2,203M · 11.6%
Latin America$567.3M → $1,207M · 9.9%
Middle East and Africa$436.4M → $920.4M · 9.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.282026
10.302027
10.302028
10.332029
10.342030
10.332031
10.362032
10.372033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- 3M Company13.0
- Sage Products LLC (a division of Stryker)19.6
- Mölnlycke Health Care9.0
- Medline Industries Inc.9.3
- Avanos Medical Inc.13.6
- Dynarex Corporation7.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type28.5%
End-Use Application16.0%
Distribution Channel21.0%
Formulation Type13.2%
User Type21.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.6
- Europe24.0
- Asia Pacific22.1
- Latin America12.1
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| 3M Company | 90 | 88 | 83 | 91 | 93 | 91 | 89 |
| Sage Products LLC (a division of Stryker) | 69 | 89 | 74 | 91 | 71 | 72 | 78 |
| Mölnlycke Health Care | 82 | 63 | 86 | 77 | 80 | 74 | 77 |
| Medline Industries Inc. | 82 | 76 | 70 | 60 | 58 | 61 | 68 |
| Avanos Medical Inc. | 59 | 75 | 65 | 76 | 65 | 52 | 65 |
| Dynarex Corporation | 56 | 54 | 47 | 56 | 62 | 60 | 56 |
| Cardinal Health Inc. | 63 | 54 | 43 | 59 | 57 | 51 | 55 |
| B. Braun Melsungen AG | 41 | 44 | 43 | 58 | 45 | 48 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- 3M Company
- Sage Products LLC (a division of Stryker)
- Mölnlycke Health Care
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| 3M Company | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Sage Products LLC (a division of Stryker) | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Mölnlycke Health Care | ✓ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Medline Industries Inc. | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Avanos Medical Inc. | − | ◐ | ◐ | ◐ | − | − |
| Dynarex Corporation | − | ◐ | ◐ | ◐ | − | − |
| Cardinal Health Inc. | ◐ | ◐ | − | ◐ | − | − |
| B. Braun Melsungen AG | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →13M Company89
2Sage Products LLC (a division of Stryker)78
3Mölnlycke Health Care77
4Medline Industries Inc.68
5Avanos Medical Inc.65
6Dynarex Corporation56
7Cardinal Health Inc.55
8B. Braun Melsungen AG47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
3M CompanySage Products LLC (a division of Stryker)
Challenger2
Strong scale, closing on the leaders.
Mölnlycke Health CareMedline Industries Inc.
Contender1
Focused players with pockets of strength.
Avanos Medical Inc.
Niche3
Specialists in a single segment or region.
Dynarex CorporationCardinal Health Inc.B. Braun Melsungen AG
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across 2% Chlorhexidine Gluconate (CHG) Cloths Market — a $252M beachhead inside a $4.51B market.
Beachhead (SOM)$252Mobtainable near-term
Serviceable (SAM)$1.56Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Pre-moistened Cloths
Best fit — highest urgency & budget in Product Type.
Economic buyer81 fit
Sterile Wipes
Strong fit — clear ROI and a fast path to value.
End user66 fit
Non-sterile Wipes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-Use Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Distribution Channel
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel29%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win 2% Chlorhexidine Gluconate (CHG) Cloths Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation15%
Closed-won7%
$21.2KCAC
$105KLTV
5.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
2% Chlorhexidine Gluconate (CHG) Cloths Market is a resilient opportunity — $3.97B by 2033, compounding at 4.0%.
TAM · 2025$2.89Btoday
TAM · 2033$3.97Bforecast
CAGR4.0%2027–2033
Cumulative$30.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.97BTotal addressable market
SAM$1.66BServiceable available market
SOM$326MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.0% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.97BLarge & growingTAM by 2033 at 4.0% CAGR
$1.66BServiceable nowreachable with today’s model
$326MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.09BBear2.6% CAGR
$3.97BBase4.0% CAGR
$5.08BBull5.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-Use Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
2% Chlorhexidine Gluconate (CHG) Cloths Market — a $3.33B market by 2033. Plan: grow share from 8.1% to 12.9%.
Market size · 2033$3.33Btotal addressable
Market CAGR4.2%2027–2033
Target share12.9%from 8.1% today
Revenue ambition$430Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.1% | 12.9% | Ahead |
| Revenue | $287M | $430M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 28.8% | 39.5% | On track |
| Customer retention | 86.9% | 93.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-Use Application capability
A defensible second engine — invest in End-Use Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-Use Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $55M capacity & capability investment
- Greenlight bolt-on M&A in End-Use Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the 2% Chlorhexidine Gluconate (CHG) Cloths Market conversation — a $2.23B market you can size, segment and defend in minutes.
Market size · 2033$2.23Btotal opportunity
Growth8.7%CAGR to 2033
Addressable buyers1,222+accounts in scope
Typical ROI6.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.8×return on cost, year one
< 3 mopayback period
$64K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
3M CompanySage Products LLC (a division of Stryker)Mölnlycke Health CareMedline Industries Inc.Avanos Medical Inc.Dynarex CorporationCardinal Health Inc.B. Braun Melsungen AG+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your 2% Chlorhexidine Gluconate (CHG) Cloths Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
2% Chlorhexidine Gluconate (CHG) Cloths Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →2-Azido-2-deoxy-D-galactose Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View report2-Aminobenzamide Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportβ2 Adrenoceptor Agonists Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View report2,6-Diaminopurine Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View report2,6-Diaminopurine (CAS 1904-98-9) Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View report2-(6-aminopyridin-3-yl)propan-2-ol Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View report266nm Laser Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View report25-Hydroxy Vitamin D(25-OH VD) Test Kit Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View report24-Well Microplates Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View report2,4-Thiazolidinedione Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View report24 Hr Holter Monitor Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View report24 Hour Urine Collection Containers Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.